Animals and plants constitute a very small part of our native biodiversity (roughly 5%). The vast majority – fungi, bacteria and the enormous diversity of other microscopic organisms, including invertebrates – is a massive, largely unexplored economic resource.
The best known examples of commercial uses for biodiversity are the thousands of drugs secreted by bacteria and fungi. But others are examples of what is known as “bio-inspiration” and “bio-mimicry”, where wild species provide the blueprints for products. The combination of nature and biotechnology can offer us all a tentative reason to hope for the future.
